Compliance To Proton Pump Inhibitors Reduces Costs
A new study reveals that patients with gastroesophageal reflux disease (GERD) who receive proton pump inhibitor (PPI) drugs require fewer health care services and incur lower costs if they conform to the recommended usage frequency.
More: continued here
Filed under: Acid Reflux/GERD on July 31st, 2008